全文获取类型
收费全文 | 1229篇 |
免费 | 57篇 |
国内免费 | 36篇 |
专业分类
耳鼻咽喉 | 13篇 |
儿科学 | 27篇 |
妇产科学 | 15篇 |
基础医学 | 188篇 |
口腔科学 | 28篇 |
临床医学 | 78篇 |
内科学 | 212篇 |
皮肤病学 | 29篇 |
神经病学 | 28篇 |
特种医学 | 165篇 |
外科学 | 96篇 |
综合类 | 123篇 |
预防医学 | 57篇 |
眼科学 | 102篇 |
药学 | 89篇 |
1篇 | |
中国医学 | 2篇 |
肿瘤学 | 69篇 |
出版年
2024年 | 3篇 |
2023年 | 12篇 |
2022年 | 6篇 |
2021年 | 23篇 |
2020年 | 7篇 |
2019年 | 15篇 |
2018年 | 22篇 |
2017年 | 22篇 |
2016年 | 24篇 |
2015年 | 27篇 |
2014年 | 53篇 |
2013年 | 73篇 |
2012年 | 71篇 |
2011年 | 64篇 |
2010年 | 53篇 |
2009年 | 61篇 |
2008年 | 63篇 |
2007年 | 80篇 |
2006年 | 55篇 |
2005年 | 40篇 |
2004年 | 37篇 |
2003年 | 29篇 |
2002年 | 33篇 |
2001年 | 18篇 |
2000年 | 14篇 |
1999年 | 14篇 |
1998年 | 41篇 |
1997年 | 40篇 |
1996年 | 39篇 |
1995年 | 25篇 |
1994年 | 21篇 |
1993年 | 23篇 |
1992年 | 10篇 |
1991年 | 8篇 |
1990年 | 8篇 |
1989年 | 24篇 |
1988年 | 19篇 |
1987年 | 15篇 |
1986年 | 21篇 |
1985年 | 18篇 |
1984年 | 5篇 |
1983年 | 5篇 |
1982年 | 17篇 |
1981年 | 9篇 |
1980年 | 12篇 |
1978年 | 6篇 |
1977年 | 9篇 |
1976年 | 9篇 |
1975年 | 7篇 |
1953年 | 2篇 |
排序方式: 共有1322条查询结果,搜索用时 15 毫秒
91.
Jiyeon Kweon Jung-Ki Yoon An-Hee Jang Ha Rim Shin Ji-Eun See Gayoung Jang Jong-Il Kim Yongsub Kim 《Molecular therapy》2021,29(6):2001-2007
- Download : Download high-res image (94KB)
- Download : Download full-size image
92.
ABM Kharsany N Hancock JA Frohlich HR Humphries SS Abdool Karim Q Abdool Karim 《HIV medicine》2010,11(10):661-665
Objectives
The aim of this study was to evaluate the HIV‐1 RNA pooled nucleic acid amplification testing (NAAT) strategy to screen pregnant women in the ‘window period’ of acute HIV infection (AHI) in rural South Africa.Methods
In 2007 and 2008, 750 consecutive pregnant women on their first antenatal care visit to a primary health care clinic were tested anonymously for HIV infection. HIV‐1 RNA pooled NAAT was performed on HIV antibody‐negative samples. All positive pools were tested individually and positive samples were classified as incident cases to calculate HIV incidence.Results
The overall HIV prevalence was 37.3% [95% confidence interval (CI) 34.3–41.3]. Of the 467 HIV antibody‐negative samples, four (0.9%) were HIV‐1 RNA‐positive. The mean viral load in the four samples was 386 260 HIV‐1 RNA copies/mL (range 64 200–1 228 130). The HIV incidence was 11.2% per year (95% CI 0.3–22.1) and all women with AHI were ≤21 years of age.Conclusions
Identifying AHI in pregnancy is important for health interventions to reduce perinatal and heterosexual transmission of HIV, and to estimate HIV incidence for epidemiological surveillance. 相似文献93.
Type 2 granular corneal dystrophy (GCD2) is caused by point mutation R124H in the transforming growth factor-β-induced gene (TGFBI) and is characterized by age-dependent progression of corneal deposits. Mitochondrial features in heterozygous GCD2 and normal corneal tissues was evaluated using electron microscopy. Primary corneal fibroblasts of homozygous and normal corneas were cultured to passage 4 or 8. Keratocytes of normal corneal tissue are narrow, and details of their intracellular organelles are difficult to distinguish. Keratocytes of heterozygous GCD2 tissues exhibited many degenerative mitochondria. MitoTracker and cytochrome c staining demonstrated increased mitochondrial activity in mutated cells at early passages. Decreases in depolarized mitochondria, cellular proliferation, and expression of complexes I to V and increases in apoptotic change were observed in late-passage mutant fibroblasts. PGC-1α, ANT-1, p-Akt, and p-mTOR but not NF-κB expression demonstrated a passage-dependent decrease in all cells. Increased passage- or mutation-related intracellular reactive oxygen species and delayed proliferation of methanethiosulfonate (MTS) were recovered using application of antioxidant butylated hydroxyanisole. Mitochondrial features and function were altered in mutated GCD2 keratocytes, in particular in older cells. Alteration of mitochondrial function is critical for understanding the pathogenesis of GCD2. 相似文献
94.
Clevudine is highly efficacious in hepatitis B e antigen-negative chronic hepatitis B with durable off-therapy viral suppression 总被引:2,自引:0,他引:2
Yoo BC Kim JH Kim TH Koh KC Um SH Kim YS Lee KS Han BH Chon CY Han JY Ryu SH Kim HC Byun KS Hwang SG Kim BI Cho M Yoo K Lee HJ Hwang JS Kim YS Lee YS Choi SK Lee YJ Yang JM Park JW Lee MS Kim DG Chung YH Cho SH Choi JY Kweon YO Lee HY Jeong SH Yoo HW Lee HS 《Hepatology (Baltimore, Md.)》2007,46(4):1041-1048
Clevudine is a pyrimidine analog with potent and sustained antiviral activity against HBV. In the present study, we evaluated the safety and efficacy of clevudine 30 mg daily for 24 weeks and assessed the durability of antiviral response for 24 weeks after cessation of dosing in hepatitis B e antigen (HBeAg)-negative chronic hepatitis B (e-CHB). We randomized a total of 86 patients (3:1) to receive clevudine 30 mg (n = 63) or placebo (n = 23) daily for 24 weeks. We followed patients for an additional 24 weeks after withdrawal of treatment. The median changes in HBV DNA from baseline were -4.25 and -0.48 log(10) copies/mL at week 24 in the clevudine and placebo groups, respectively (P < 0.0001). Viral suppression in the clevudine group was sustained after withdrawal of therapy, with 3.11 log(10) reduction at week 48. At week 24 and week 48, 92.1% and 16.4% of patients in the clevudine group had undetectable serum HBV DNA levels by Amplicor PCR assay (<300 copies/mL). The proportion of patients who achieved ALT normalization was 74.6% and 33.3% in the clevudine and placebo groups at week 24, respectively (P = 0.0006). ALT normalization in the clevudine group was well-maintained during the post-treatment follow-up period. The incidence of adverse events was similar in the 2 groups. No resistance to clevudine was detected during treatment. CONCLUSION: A 24-week clevudine therapy was well-tolerated and showed potent and sustained antiviral effect without evidence of viral resistance in e-CHB patients. However, treatment for longer than 24 weeks would be needed to achieve durable remission. 相似文献
95.
Yang Y Shin JY Oh JM Jung CH Hwang Y Kim S Kim JS Yoon KJ Ryu JY Shin J Hwang JS Yoon TY Shin YK Kweon DH 《Proceedings of the National Academy of Sciences of the United States of America》2010,107(51):22145-22150
Neuronal SNARE proteins mediate neurotransmitter release at the synapse by facilitating the fusion of vesicles to the presynaptic plasma membrane. Cognate v-SNAREs and t-SNAREs from the vesicle and the plasma membrane, respectively, zip up and bring about the apposition of two membranes attached at the C-terminal ends. Here, we demonstrate that SNARE zippering can be modulated in the midways by wedging with small hydrophobic molecules. Myricetin, which intercalated into the hydrophobic inner core near the middle of the SNARE complex, stopped SNARE zippering in motion and accumulated the trans-complex, where the N-terminal region of v-SNARE VAMP2 is in the coiled coil with the frayed C-terminal region. Delphinidin and cyanidin inhibited N-terminal nucleation of SNARE zippering. Neuronal SNARE complex in PC12 cells showed the same pattern of vulnerability to small hydrophobic molecules. We propose that the half-zipped trans-SNARE complex is a crucial intermediate waiting for a calcium trigger that leads to fusion pore opening. 相似文献
96.
Prevalence of osteoporosis and reference data for lumbar spine and hip bone mineral density in a Korean population 总被引:1,自引:0,他引:1
Cui LH Choi JS Shin MH Kweon SS Park KS Lee YH Nam HS Jeong SK Im JS 《Journal of bone and mineral metabolism》2008,26(6):609-617
The aims of this study were to establish reference data for bone mineral density (BMD) at central skeletal sites using Lunar
dual-energy X-ray absorptiometry (DXA), and to estimate the age-and sex-specific prevalence of osteoporosis in a Korean population.
We performed a population-based, cross-sectional study. The subjects were 4148 (1810 men and 2338 women) Korean adults, aged
20–79 years. The BMD for central sites (lumbar spine, femoral neck, trochanter, and Ward’s triangle) were measured by DXA.
The standardized prevalence of osteoporosis among individual aged 50–79 years in lumbar spine, femoral neck, Ward’s triangle,
and trochanter was 40.1%, 12.4%, 28.4%, and 4.4% in women and 6.5%, 5.9%, 3.7%, and 1.6% in men, respectively. In women, peak
BMD occurred in the age range 40–49 years for the femoral neck and trochanter, 30–39 years for the lumbar spine, and 20–29
years for Ward’s triangle. In men, peak BMD values were observed at 20–29 years for all measured sites. This study establishes
a normative database for BMD at central skeletal sites using dualenergy X-ray absorptiometry and provides more reliable information
on the prevalence of osteoporosis in Korea. 相似文献
97.
98.
Multicenter Analysis of Clinical Features and Prognosis of COVID-19 Patients with Hepatic Impairment
Jeong Eun Song Min Kyu Kang Yu Rim Lee Chang Hyeong Lee Jung Gil Park Young Oh Kweon Won Young Tak Soo Young Park Se Young Jang Jae Seok Hwang Byoung Kuk Jang Won Young Jang Jeong Ill Suh Woo Jin Chung Byung Seok Kim Daegu-Gyeongbuk Liver Study Group 《Gut and liver》2021,15(4):606
Background/AimsRecent data indicate the presence of liver enzyme abnormalities in patients with coronavirus disease 2019 (COVID-19). We aimed to evaluate the clinical features and treatment outcomes of COVID-19 patients with abnormal liver enzymes.MethodsWe performed a retrospective, multicenter study of 874 COVID-19 patients admitted to five tertiary hospitals from February 20 to April 14, 2020. Data on clinical features, laboratory parameters, medications, and treatment outcomes were collected until April 30, 2020, and compared between patients with normal and abnormal aminotransferases.ResultsAbnormal aminotransferase levels were observed in 362 patients (41.1%), of which 94 out of 130 (72.3%) and 268 out of 744 (36.0%) belonged to the severe and non-severe COVID-19 categories, respectively. The odds ratios (95% confidence interval) for male patients, patients with a higher body mass index, patients with severe COVID-19 status, and patients with lower platelet counts were 1.500 (1.029 to 2.184, p=0.035), 1.097 (1.012 to 1.189, p=0.024), 2.377 (1.458 to 3.875, p=0.001), and 0.995 (0.993 to 0.998, p>0.001), respectively, indicating an independent association of these variables with elevated aminotransferase levels. Lopinavir/ritonavir and antibiotic use increased the odds ratio of abnormal aminotransferase levels after admission (1.832 and 2.646, respectively, both p<0.05). The median time to release from quarantine was longer (22 days vs 26 days, p=0.001) and the mortality rate was higher (13.0% vs 2.9%, p<0.001) in patients with abnormal aminotransferase levels.ConclusionsAbnormal aminotransferase levels are common in COVID-19 patients and are associated with poor clinical outcomes. Multivariate analysis of patients with normal aminotransferase levels on admission showed that the use of lopinavir/ritonavir and antibiotics was associated with abnormal aminotransferase levels; thus, careful monitoring is needed. 相似文献
99.
Moon du G Yang DY Lee CH Ahn TY Min KS Park K Park JK Kim JJ 《The journal of sexual medicine》2011,8(7):2048-2061
IntroductionPatients with diabetes mellitus (DM) are reported to experience more severe erectile dysfunction (ED) symptoms and respond less to ED treatments compared with patients with ED of other etiologies.AimThis study was undertaken to evaluate the safety and efficacy of udenafil for the treatment of ED in a larger number of patients with DM.MethodsA placebo‐controlled, randomized, double‐blind, double‐dummy, parallel‐group design multicenter study, fixed‐dose trial was conducted. The trial involved seven study sites in Korea, with 174 ED patients with DM. The subjects, treated with placebo, 100 mg, or 200 mg of udenafil for 12 weeks, were asked to complete the International Index of Erectile Function (IIEF), the Sexual Encounter Profile (SEP) diary, and the Global Assessment Question (GAQ) during the study period.Main Outcome MeasuresThe primary efficacy parameter was the change in the erectile function domain (EFD) score of IIEF from baseline. Secondary parameters were IIEF questions 3 (Q3) and Q4, SEP Q2 and Q3, rate of achieving normal erectile function (EFD ≥ 26), and the response to GAQ.ResultsCompared with the placebo, patients receiving both doses of udenafil showed statistically significant improvements in the IIEF‐EFD score, respectively. However, statistically significant difference was not observed between the udenafil 100 mg and the udenafil 200 mg groups. Similar results were observed in the comparison of Q3 and Q4 of IIEF, SEP diary, and GAQ. The percentages of subjects experiencing at least one adverse event related to the study drugs were 3.6%, 15.8%, and 22.4% for the placebo, udenafil 100 mg, and udenafil 200 mg groups, respectively. However, these events were all mild in severity. Major adverse events were flushing, headache, nausea, and conjunctival hyperemia.ConclusionUdenafil was significantly effective for the treatment of ED, demonstrating statistically significant improvement in erectile function in patients with DM. The incidence of adverse events was relatively low and well tolerated in patients with DM. Moon DG, Yang DY, Lee CH, Ahn TY, Min KS, Park K, Park CK, and Kim JJ. A therapeutic confirmatory study to assess the safety and efficacy of Zydena® (udenafil) for the treatment of erectile dysfunction in male patients with diabetes mellitus. J Sex Med 2011;8:2048–2061. 相似文献
100.
Pomegranate fruit extract inhibits prosurvival pathways in human A549 lung carcinoma cells and tumor growth in athymic nude mice 总被引:3,自引:0,他引:3
Developing novel mechanism-based chemopreventive approaches for lung cancer through the use of dietary substances which humans can accept has become an important goal. In the present study, employing normal human bronchial epithelial cells (NHBE) and human lung carcinoma A549 cells, we first compared the growth inhibitory effects of pomegranate fruit extract (PFE). Treatment of PFE (50-150 microg/ml) for 72 h was found to result in a decrease in the viability of A549 cells but had only minimal effects on NHBE cells as assessed by the MTT and Trypan blue assays. PFE treatment of A549 cells also resulted in dose-dependent arrest of cells in G0-G1 phase of the cell cycle (as assessed by DNA cell cycle analysis). We further found that PFE treatment also resulted in (i) induction of WAF1/p21 and KIP1/p27, (ii) decrease in the protein expressions of cyclins D1, D2 and E, and (iii) decrease in cyclin-dependent kinase (cdk) 2, cdk4 and cdk6 expression. The treatment of cells with PFE inhibited (i) phosphorylation of MAPK proteins, (ii) inhibition of PI3K, (iii) phosphorylation of Akt at Thr308, (iv) NF-kappaB and IKKalpha, (v) degradation and phosphorylation of IkappaBalpha, and (vi) Ki-67 and PCNA. We also found that PFE treatment to A549 cells resulted in inhibition of NF-kappaB DNA-binding activity. Oral administration of PFE (0.1 and 0.2%, wt/vol) to athymic nude mice implanted with A549 cells resulted in a significant inhibition in tumor growth. Our results provide a suggestion that PFE can be a useful chemopreventive/chemotherapeutic agent against human lung cancer. 相似文献